share_log

Acrivon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(13.6%),Joseph Edelman(13.6%), etc.

Acrivon Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(13.6%),Joseph Edelman(13.6%)等

SEC announcement ·  02/14 17:37
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息